Engineering a pure and stable heterodimeric IgA for the development of multispecific therapeutics

MAbs. 2022 Jan-Dec;14(1):2141637. doi: 10.1080/19420862.2022.2141637.

Abstract

CE-SDS: capillary electrophoresis sodium dodecyl sulfate; DSC: differential scanning calorimetry; FACS: fluorescence-activated cell sorting; FSA: full-sized antibody; Her2: human epidermal growth factor receptor 2; MFI: mean fluorescent intensity; OAA: one-armed antibody; PBS: phosphate-buffered saline; PDB: Protein Data Bank; SEC: size-exclusion chromatography; prepSEC (preparative SEC); RMSD: root-mean-square deviation; RU: resonance units; SPR: surface plasmon resonance; TAA: tumor-associated antigen; WT: wild-type.

Keywords: Fc engineering; IgA therapeutics; antibody engineering; antibody stability; biophysical characterization of antibody; bispecific antibody; heterodimeric antibody; multivalent scaffold; quality by design.

MeSH terms

  • Chromatography, Gel
  • Humans
  • Immunoglobulin A*

Substances

  • Immunoglobulin A

Grants and funding

The author(s) reported that there is no funding associated with the work featured in this article.